<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Evidence from retrospective studies suggests that the risk of <z:mp ids='MP_0005048'>thrombosis</z:mp> is related to the dose of <z:chebi fb="67" ids="50114">oestrogen</z:chebi> in oral contraceptives </plain></SENT>
<SENT sid="1" pm="."><plain>Postoperative <z:mp ids='MP_0005048'>thrombosis</z:mp> is four times more likely to occur if oral contraceptives containing <z:chebi fb="67" ids="50114">oestrogen</z:chebi> are used before a major surgical procedure </plain></SENT>
<SENT sid="2" pm="."><plain>Older women who smoke are at greater risk, especially when the surgery is performed during the winter months </plain></SENT>
<SENT sid="3" pm="."><plain>It is recommended that barrier methods of contraception (condom or vaginal diaphragm) be employed during the six weeks before an elective major surgical procedure or that a <z:chebi fb="13" ids="50745">progestogen</z:chebi>-only pill be used in place of a combined or sequential oral contraceptive for this period of time </plain></SENT>
</text></document>